Literature DB >> 35059114

Cyclic ADP Ribose Hydrolase (CD38) Inhibitors.

Benjamin E Blass1.   

Abstract

Entities:  

Year:  2021        PMID： 35059114      PMCID： PMC8762756          DOI： 10.1021/acsmedchemlett.1c00647

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN： 1948-5875            Impact factor:   4.345


× No keyword cloud information.
  3 in total

Review 1.  CD38: A Potential Therapeutic Target in Cardiovascular Disease.

Authors:  Wanyun Zuo; Na Liu; Yunhong Zeng; Yaozhong Liu; Biao Li; Keke Wu; Yunbin Xiao; Qiming Liu
Journal:  Cardiovasc Drugs Ther       Date:  2021-08       Impact factor: 3.727

Review 2.  CD38 and Regulation of the Immune Response Cells in Cancer.

Authors:  Sanyog Dwivedi; Erika P Rendón-Huerta; Vianney Ortiz-Navarrete; Luis F Montaño
Journal:  J Oncol       Date:  2021-02-27       Impact factor: 4.375

Review 3.  CD38-Directed Therapies for Management of Multiple Myeloma.

Authors:  Hamza Hashmi; Muhammad Husnain; Ali Khan; Saad Z Usmani
Journal:  Immunotargets Ther       Date:  2021-06-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.